BlackRock Institutional Trust’s THERAGENICS CORP TGX Stock Holding History
Bought
Maintained
Sold
BlackRock Institutional Trust's TGX Position: Q4 2013 in Review
BlackRock Institutional Trust sold out of THERAGENICS CORP (TGX) in Q4 2013, closing a stake of 1,305,902 shares — an estimated $2.85M sold.
BlackRock Institutional Trust first reported a position in TGX in Q2 2013 and held it in 2 quarters. The position peaked at $2.85M in Q3 2013. 0 funds tracked by Wall St. Rank hold TGX as of Q4 2013.
- BlackRock Institutional Trust reported no remaining THERAGENICS CORP position as of Q4 2013 after selling out during the quarter.
- BlackRock Institutional Trust sold 1,305,902 THERAGENICS CORP shares in Q4 2013, an estimated $2.85M.
- BlackRock Institutional Trust first reported a position in THERAGENICS CORP in Q2 2013 and held it in 2 quarters.
- BlackRock Institutional Trust's THERAGENICS CORP position peaked at $2.85M in Q3 2013.
- 0 funds tracked by Wall St. Rank held THERAGENICS CORP as of Q4 2013.
Based on BlackRock Institutional Trust's 13F filing for Q4 2013, filed 12 Feb 2014.